Emergent BioSolutions is being tracked by MarketBeat, benchmarking its volatility against the S&P 500, while also competing with Viridian Therapeutics.
1 report, 1 independent
Updated Oct 6
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Emergent BioSolutions is being tracked by MarketBeat, benchmarking its volatility against the S&P 500, while also competing with Viridian Therapeutics.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Emergent BioSolutions
multinational biopharmaceutical company headquartered in Gaithersburg, Maryland, USA
Nothing else this week.
-
MarketBeat
American personal finance blog
Related events
- MarketBeat reported analyst recommendations for Broadwind Energy and LiqTech International, noting their volatility compared to the S&P 500.
- MarketBeat provided analyst ratings and compared the stock volatility of Rambus and ACM Research against the S&P 500.
- MarketBeat reported analyst recommendations for Cytokinetics and Gain Therapeutics, two competing healthcare companies.